Efficacy and tolerability of nortriptyline in the management of neuropathic corneal pain

Ozmen, MEHMET; Dieckmann, Gabriela; Cox, Stephanie; Rashad, Ramy; Paracha, Rumzah; Sanayei, Nedda; Morkin, Melina; Hamrah, Pedram

doi:10.1016/j.jtos.2020.08.006

Efficacy and tolerability of nortriptyline in the management of neuropathic corneal pain

Ozmen M. C., Dieckmann G., Cox S. M., Rashad R., Paracha R., Sanayei N., ...Daha Fazla

OCULAR SURFACE, cilt.18, sa.4, ss.814-820, 2020 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 18 Sayı: 4
Basım Tarihi: 2020
Doi Numarası: 10.1016/j.jtos.2020.08.006
Dergi Adı: OCULAR SURFACE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
Sayfa Sayıları: ss.814-820
Anahtar Kelimeler: Neuropathic corneal pain, Dry eye disease, Nortriptyline, Tricyclic antideppressant, Sensitization, POSTHERPETIC NEURALGIA, OCULAR PAIN, DRY EYE, PLACEBO, ANTIDEPRESSANTS, SYMPTOMS, SENSATION, NERVE, TRIAL
Gazi Üniversitesi Adresli: Evet

Özet

Purpose: Neuropathic corneal pain (NCP) is a recently acknowledged disease entity. However, there is no consensus in potential treatment strategies, particularly in patients with a centralized component of pain. This study aims to assess the efficacy and tolerability of the tricyclic antidepressant, nortriptyline, among NCP patients.